Fundraising Fox
Vitalief
New Brunswick, US · Founded 2021 · Delaware corporation · 16 employees on LinkedIn · 1 known investors
Find your way into Vitalief
Sign up to see every warm intro you have to Vitalief
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vitalief team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vitalief is a research operations partner that embeds experienced staff inside clinical research programs to run work across study start-up, financial and revenue cycle operations, workforce capacity, and portfolio delivery. It serves clinical research organizations and sponsors across the United States.
Founders & leadership
SL
Steven Libutti, M.D.Named on SEC filing
JD
John DollNamed on SEC filing
RA
Reynold A. Panettieri, M.D.Named on SEC filing
DG
David GraneseNamed on SEC filing
DC
David C. MooreNamed on SEC filing
KM
Kirk McPoyleNamed on SEC filing
Board
ME
Investors · 1
Reported raises · per SEC filings
Form D private placements$4.8M disclosed across 2 rounds · 2022–2023
▶$2MraisedApr 2023 · 3 investors · OtherRule 506(b)
▶$2MraisedApr 2023 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Steven Libutti, M.D.Director
- John DollDirector
- Mark E. KolbDirector
- Reynold A. Panettieri, M.D.Director
- David GraneseExecutive Officer
- David C. MooreExecutive Officer, Director
- Kirk McPoyleExecutive Officer
- Offering amount
- $3M
- Amount sold
- $2M
- Proceeds to insiders
- $200K
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$2.8MraisedMay 2022 · 4 investors · OtherRule 506(b)
▶$2.8MraisedMay 2022 · 4 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- MARK E. KOLBExecutive Officer, Director
- DAVID C. MOOREExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $2.8M
- Proceeds to insiders
- $200K
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
AdvarraAdvarra provides clinical research services and technology, including institutional review board (IRB) and institutional biosafety committee (IBC) review, data monitoring, endpoint adjudication, and consulting, along with software platforms for clinical trials. It serves life sciences companies, research sites, and institutions in the clinical research industry.
WcgclinicalWCG advances clinical trial efficiency and outcomes through research services and advisory support. The company serves the medical research and clinical trial industry.
TremendousTremendous operates a platform that enables organizations to issue payouts in the form of money, prepaid cards, and gift cards to recipients globally. The service is used by businesses, nonprofits, researchers, and marketers to automate reward and incentive distribution across 200+ regions.
Companies working in the same space as Vitalief.
Frequently asked questions
- What does Vitalief do?
- Vitalief is a research operations partner that embeds experienced staff inside clinical research programs to run work across study start-up, financial and revenue cycle operations, workforce capacity, and portfolio delivery. It serves clinical research organizations and sponsors across the United States.
- Who are Vitalief's investors?
- Vitalief's investors include Tech Council Ventures.
- How much funding has Vitalief raised?
- Vitalief has disclosed $4.8M raised across 2 rounds.
- Where is Vitalief headquartered?
- Vitalief is headquartered in New Brunswick, US.